Pectoralis Minor Release Versus Non-release in RSA

Recruiting now · Not applicable

Conditions studied: Reverse Total Shoulder Arthroplasty, Rotator Cuff Tear Arthropathy, Advanced Glenohumeral Osteoarthritis

In brief

The goal of this clinical trial is to assess if concomitant open pectoralis minor release would improve pain and outcomes after Reverse Shoulder Arthroplasty (RSA). The main questions it aims to answer are: * whether releasing the pectoralis minor prophylactically could have better pain relief * whether releasing the pectoralis minor prophylactically could have increased Range of motion (ROM) outcomes * whether releasing the pectoralis minor prophylactically could have higher final Patient Reported Outcome Measurements (PROMs) Participants will be randomized to either undergo RSA with pectoralis minor release or RSA without pectoralis minor release.

Key facts

Study ID

NCT06292169

Run by

Emory University

People needed

90

Starts

2024-08-07

Expected to finish

2026-01-01

Last updated by the study team

2025-10-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients undergoing surgery for reverse total shoulder arthroplasty
• Patients willing and able to provide informed consent

You may not qualify if…

• Revision arthroplasty
• Reverse shoulder arthroplasty for proximal humerus fractures
• Adults unable to consent
• Individuals who are not yet adults (infants, children, teenagers)
• Pregnant women
• Prisoners

Where it is running

• Emory Clinic — Atlanta, Georgia, United States (enrolling)
• Emory Healthcare Orthopaedics and Spine Center — Atlanta, Georgia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.